EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,307,570 | -33.0% | 1,561,050 | +44.8% | 0.00% | 0.0% |
| Q2 2023 | $7,926,372 | -6.8% | 1,078,418 | +31.3% | 0.00% | -33.3% |
| Q1 2023 | $8,507,839 | +4.0% | 821,220 | +18.5% | 0.00% | 0.0% |
| Q4 2022 | $8,182,393 | -30.9% | 692,836 | +22.9% | 0.00% | -25.0% |
| Q3 2022 | $11,835,000 | -24.6% | 563,801 | +11.5% | 0.00% | -20.0% |
| Q2 2022 | $15,696,000 | -21.6% | 505,646 | +3.7% | 0.01% | -16.7% |
| Q1 2022 | $20,029,000 | -1.9% | 487,778 | +3.9% | 0.01% | 0.0% |
| Q4 2021 | $20,417,000 | -10.1% | 469,665 | +3.5% | 0.01% | -14.3% |
| Q3 2021 | $22,715,000 | -32.8% | 453,659 | -15.5% | 0.01% | -36.4% |
| Q2 2021 | $33,822,000 | -29.2% | 536,941 | +4.4% | 0.01% | -38.9% |
| Q1 2021 | $47,778,000 | -11.1% | 514,230 | -14.3% | 0.02% | -14.3% |
| Q4 2020 | $53,768,000 | -14.4% | 600,086 | -1.3% | 0.02% | -27.6% |
| Q3 2020 | $62,816,000 | +70.4% | 607,912 | +30.4% | 0.03% | +61.1% |
| Q2 2020 | $36,866,000 | +26.1% | 466,186 | -7.7% | 0.02% | +5.9% |
| Q1 2020 | $29,235,000 | +8.5% | 505,269 | +1.1% | 0.02% | +21.4% |
| Q4 2019 | $26,957,000 | +7.9% | 499,660 | +4.5% | 0.01% | -6.7% |
| Q3 2019 | $24,992,000 | +7.6% | 478,023 | -0.5% | 0.02% | +7.1% |
| Q2 2019 | $23,220,000 | -5.6% | 480,641 | -1.3% | 0.01% | -12.5% |
| Q1 2019 | $24,603,000 | -4.9% | 486,982 | +11.6% | 0.02% | -20.0% |
| Q4 2018 | $25,862,000 | -14.5% | 436,254 | -5.0% | 0.02% | 0.0% |
| Q3 2018 | $30,242,000 | +37.0% | 459,384 | +5.1% | 0.02% | +25.0% |
| Q2 2018 | $22,077,000 | -6.1% | 437,243 | -2.1% | 0.02% | -11.1% |
| Q1 2018 | $23,514,000 | +6.6% | 446,591 | -5.9% | 0.02% | +5.9% |
| Q4 2017 | $22,049,000 | -11.8% | 474,478 | -23.2% | 0.02% | -22.7% |
| Q3 2017 | $24,991,000 | +4.7% | 617,823 | -12.2% | 0.02% | 0.0% |
| Q2 2017 | $23,867,000 | +17.0% | 703,811 | +0.2% | 0.02% | +10.0% |
| Q1 2017 | $20,400,000 | -9.6% | 702,459 | +2.3% | 0.02% | -20.0% |
| Q4 2016 | $22,561,000 | -1.1% | 686,981 | -5.1% | 0.02% | -7.4% |
| Q3 2016 | $22,819,000 | +9.8% | 723,709 | -2.1% | 0.03% | +3.8% |
| Q2 2016 | $20,789,000 | +8.4% | 739,287 | +40.2% | 0.03% | +4.0% |
| Q1 2016 | $19,170,000 | -18.5% | 527,351 | -10.3% | 0.02% | -21.9% |
| Q4 2015 | $23,513,000 | +48.1% | 587,656 | +5.4% | 0.03% | +39.1% |
| Q3 2015 | $15,880,000 | -16.2% | 557,359 | -3.1% | 0.02% | -11.5% |
| Q2 2015 | $18,948,000 | +27.1% | 575,046 | +11.0% | 0.03% | +23.8% |
| Q1 2015 | $14,904,000 | +19.1% | 518,187 | +12.7% | 0.02% | +10.5% |
| Q4 2014 | $12,517,000 | +55.6% | 459,666 | +21.8% | 0.02% | +46.2% |
| Q3 2014 | $8,042,000 | +1.8% | 377,340 | +7.3% | 0.01% | 0.0% |
| Q2 2014 | $7,896,000 | -3.3% | 351,528 | +8.8% | 0.01% | -13.3% |
| Q1 2014 | $8,163,000 | +45.8% | 323,000 | +32.6% | 0.02% | +36.4% |
| Q4 2013 | $5,599,000 | +126.8% | 243,515 | +91.7% | 0.01% | +120.0% |
| Q3 2013 | $2,469,000 | +13.1% | 127,046 | -13.5% | 0.01% | 0.0% |
| Q2 2013 | $2,183,000 | – | 146,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |